Dr. Brian Francis Provides Updates on Glaucoma Treatments from AAO 2007

Dr. Brian Francis of the Doheny Eye Institute covers the glaucoma highlights at this year's AAO meeting in a discussion with Dr. Andrew Moshfeghi, Associate Retina Editor for OphthalmologyWeb. Some of Dr. Francis' key points from the sessions: research presented may expand indications for SLT, randomized trial data is now available for SLT vs. ALT at 3 yrs. Surgical techniques discussed at AAO: canaloplasty, trabectome, trabecular stent, and the gold microshunt. Trials: TVT (tube vs. trabeculectomy) study update. Current thoughts on IOP: diurnal pressure control and 24hr pressure monitoring devices. New drugs: Combigan's role may be similar to Cosopt long term. Mementine data was not presented at AAO. New technologies: Fourier domain OCT looks promising but no longitudinal data yet. Dr. Francis will be initiating a trial to evaluate intracameral Lucentis injections in the treatment of neo-vascular glaucoma (NVG).